BDBM557869 1-(3-((4-((3-cyclopropyl- phenyl)amino)-7-methoxy- quinazolin-6-yl)oxy)- azetidin-1-yl)prop-2-en-1- one::US11365189, Ex. No. 31

SMILES COc1cc2ncnc(Nc3cccc(c3)C3CC3)c2cc1OC1CN(C1)C(=O)C=C

InChI Key InChIKey=SRIGNLHWFILXLC-UHFFFAOYSA-N

Data  9 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 9 hits for monomerid = 557869   

TargetReceptor tyrosine-protein kinase erbB-2 [1-775,'YVMA',776-1255](Human)
University Of Texas

US Patent
LigandPNGBDBM557869(US11365189, Ex. No. 31 | 1-(3-((4-((3-cyclopropyl-...)
Affinity DataIC50: 600nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [1-780,'GSP',781-1255](Human)
University Of Texas

US Patent
LigandPNGBDBM557869(US11365189, Ex. No. 31 | 1-(3-((4-((3-cyclopropyl-...)
Affinity DataIC50: 79nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [1-775,'VC',777-1255](Human)
University Of Texas

US Patent
LigandPNGBDBM557869(US11365189, Ex. No. 31 | 1-(3-((4-((3-cyclopropyl-...)
Affinity DataIC50: 160nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor(Human)
University Of Texas

US Patent
LigandPNGBDBM557869(US11365189, Ex. No. 31 | 1-(3-((4-((3-cyclopropyl-...)
Affinity DataIC50: 85nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [S768I](Human)
University Of Texas

US Patent
LigandPNGBDBM557869(US11365189, Ex. No. 31 | 1-(3-((4-((3-cyclopropyl-...)
Affinity DataIC50: 8.10nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [1-770,'SVD',771-1210](Human)
University Of Texas

US Patent
LigandPNGBDBM557869(US11365189, Ex. No. 31 | 1-(3-((4-((3-cyclopropyl-...)
Affinity DataIC50: 97nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [1-770,'NPG',771-1210](Human)
University Of Texas

US Patent
LigandPNGBDBM557869(US11365189, Ex. No. 31 | 1-(3-((4-((3-cyclopropyl-...)
Affinity DataIC50: 85nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [1-769,'SVD',770-1210](Human)
University Of Texas

US Patent
LigandPNGBDBM557869(US11365189, Ex. No. 31 | 1-(3-((4-((3-cyclopropyl-...)
Affinity DataIC50: 360nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [1-769,'SV',770-1210](Human)
University Of Texas

US Patent
LigandPNGBDBM557869(US11365189, Ex. No. 31 | 1-(3-((4-((3-cyclopropyl-...)
Affinity DataIC50: 220nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent